Rhein lysinate decreases the generation of β-amyloid in the brain tissues of Alzheimer's disease model mice by inhibiting inflammatory response and oxidative stress

Journal of Asian Natural Products Research

Volumn 15, Issue 7, 2013, Pages 756-763

  Liu, Jiang ^a   Hu, Gang ^b   Xu, Rong ^b   Qiao, Yue ^c   Wu, He Ping ^a   Ding, Xun ^a   Duan, Peng ^a   Tu, Ping ^a   Lin, Ya Jun ^b  

^a Third Hospital of Nanchang   (China)

^b BEIJING HOSPITAL   (China)

^c THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

amyloid; Alzheimer's disease; inflammation; rhein lysinate; SAMP8 mice

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; BRAIN PROTEIN; GLUTATHIONE PEROXIDASE; INTERLEUKIN 6; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; RHEIN; RHEIN LYSINATE; SIRTUIN 1; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; SENESCENCE ACCELERATED MOUSE;

AGING; ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PEPTIDES; ANIMALS; ANTHRAQUINONES; BRAIN; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUTATHIONE PEROXIDASE; INTERLEUKIN-6; LYSINE; MALE; MALONDIALDEHYDE; MICE; OXIDATIVE STRESS; SIRTUIN 1; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 84880220631     PISSN: 10286020     EISSN: 14772213     Source Type: Journal    
DOI: 10.1080/10286020.2013.800972     Document Type: Article

References (25)

1. A. Wimo, L. Jonsson, and B. Winblad, Dement. Geriatr. Cogn. Disord. 21, 175 (2006).
2. L.E. Hebert, P.A. Scherr, J. Bienias, D.A. Bennett, and D.A. Evans, Arch. Neurol. 60, 1119 (2003).
3. D.M. Skovronsky, V.M. Lee, and J.Q. Trojanowski, Annu. Rev. Pathol. 1, 151 (2006).
4. R.E. Tanzi, Nat. Neurosci. 8, 977 (2005).
5. R.E. Mrak and W.S. Griffin, Neurobiol. Aging 26, 349 (2005).
6. C.E. Finch and T.E. Morgan, Curr. Alzheimer Res. 4, 185 (2007).
7. M. Cacquevel, N. Lebeurrier, S. Chéenne, and D. Vivien, Curr. Drug Targets 5, 529 (2004).
8. C.K. Combs, J.C. Karlo, S.C. Kao, and G.E. Landreth, J. Neurosci. 21, 1179 (2001).
9. J. Drake, C.D. Link, and D.A. Butterfiled, Neurobiol. Aging 24, 415 (2003).
10. G.M. Pasinetti, J. Alzheimers Dis. 4, 435 (2002).
11. G.P. Lim, T. Chu, F. Yang, W. Beech, S.A. Frautschy, and G.M. Cole, J. Neurosci. 21, 8370 (2001).
12. H. Du, J. Shao, P. Gu, B. Lu, X. Ye, and Z. Liu, J. Endocrinol. Invest. 35, 607 (2012).
13. C. Malaguti, C.A. Vilella, K.P. Vieira, G.H. Souza, S. Hyslop, and L. Zollner, Int. Immunopharmacol. 8, 782 (2008).
14. G. Martin, P. Bogdanowicz, F. Domagala, H. Ficheux, and J.P. Pujol, Biorheology 41, 549 (2004).
15. P. Shi, Z. Huang, and G. Chen, Am. J. Chin. Med. 36, 805 (2008).
16. P.L. Kuo, Y.L. Hsu, L.T. Ng, and C.C. Lin, Planta. Med. 70, 12 (2004).
17. R.E. Tanzi and L. Bertram, Cell 120, 545 (2005).
18. T. Takeda, M. Hosokawa, and K. Higuchi, Exp. Gerontol. 32, 105 (1997).
19. H.M. Wang, L.W. Wang, X.M. Liu, C.L. Li, S.P. Xu, and A.D. Farooq, Pharmacol. Biochem. Behav. 105, 134 (2013).
20. G. Candore, M. Bulati, C. Caruso, L. Castiglia, G. Colonna-Romano, D. Di Bona, G. Duro, D. Lio, D. Matranga, M. Pellicanò, C. Rizzo, G. Scapagnini, and S. Vasto, Rejuvenation Res. 13, 301 (2010).
21. Y. Yao, C. Chinnici, H. Tang, J.Q. Trojanowski, V.M. Lee, and D. Praticò, J. Neuroinflammation 22, 21 (2004).
22. X. Zhu, H.G. Lee, G. Casadesus, J. Avila, K. Drew, G. Perry, and M.A. Smith, Mol. Neurobiol. 31, 205 (2005).
23. A. Bokov, A. Chaudhuri, and A. Richardson, Mech. Ageing Dev. 125, 811 (2004).
24. M.A. Smith, G. Perry, P.L. Richey, L.M. Sayre, V.E. Anderson, M.F. Beal, and N. Kowall, Nature 382, 120 (1996).
25. G. Donmez, D. Wang, D.E. Cohen, and L. Guarente, Cell 142, 320 (2010).